We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PHIL market cap is 844.31M. The company's latest EPS is EUR and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 15.05M | 6.35M | 4.96M | 27.3M | 25.12M |
| Operating Income | -1.93M | -12.13M | -16.78M | 240k | -8.84M |
| Net Income | 1.4M | -13.29M | -15.73M | -5.38M | -6.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 96.26M | 85.47M | 132.75M | 125.83M | 119.27M |
| Total Liabilities | 27.46M | 29.8M | 27.67M | 27.91M | 28.68M |
| Total Equity | 68.8M | 55.67M | 105.09M | 97.92M | 90.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 7.5M | -13.17M | -19.03M | -4.94M | -4.82M |
| Investing | -32.51M | 17.77M | -47.77M | 24.2M | 159k |
| Financing | 29.12M | 3.79M | 63.06M | -3.78M | -4.17M |
| Market Cap | 844.31M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 40.4M |
| Average Volume (1 week) | 3.72k |
| Average Volume (1 Month) | 5.76k |
| 52 Week Change | 31.45% |
| 52 Week High | 21.60 |
| 52 Week Low | 15.50 |
| Spread (Intraday) | 0.4 (1.9%) |
| Company Name | Philogen Spa |
| Address |
piazza la lizza, 7 siena, siena 53100 |
| Website | https://www.philogen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
